Achieve life sciences announces granting of new hire inducement awards

Seattle and vancouver, british columbia, july 01, 2022 (globe newswire) -- achieve life sciences, inc. (nasdaq: achv), a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced that the company has issued inducement grants of stock options to two new employees.
ACHV Ratings Summary
ACHV Quant Ranking